• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠心病的实践环境与二级预防

Practice setting and secondary prevention of coronary artery disease.

作者信息

Jankowski Piotr, Czarnecka Danuta, Badacz Leszek, Bogacki Piotr, Dubiel Jacek S, Grodecki Janusz, Grodzicki Tomasz, Maciejewicz Janusz, Mirek-Bryniarska Ewa, Nessler Jadwiga, Piotrowski Wiesław, Podolec Piotr, Śmielak-Korombel Wanda, Tracz Wiesława, Kawecka-Jaszcz Kalina, Pająk Andrzej

机构信息

First Department of Cardiology, Interventional Electrocardiology and Hypertension, Institute of Cardiology, Jagiellonian University Medical College, Krakow, Poland.

Department of Cardiology, Ludwik Rydygier District Hospital, Krakow, Poland.

出版信息

Arch Med Sci. 2018 Aug;14(5):979-987. doi: 10.5114/aoms.2017.65236. Epub 2017 Jan 19.

DOI:10.5114/aoms.2017.65236
PMID:30154878
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6111342/
Abstract

INTRODUCTION

Patients with established coronary artery disease (CAD) are at high risk of recurrent cardiovascular events. The aim of the analysis was to compare time trends in the extent to which cardiovascular prevention guidelines have been implemented by primary care physicians and specialists.

MATERIAL AND METHODS

Five hospitals with cardiology departments serving the city and surrounding districts in the southern part of Poland participated in the study. Consecutive patients hospitalized due to an acute coronary syndrome or for a myocardial revascularization procedure were recruited and interviewed 6-18 months after hospitalization. The surveys were carried out in 1997-1998, 1999-2000, 2006-2007 and 2011-2013.

RESULTS

The proportion of smokers increased from 16.0% in 1997-1998 to 16.4% in 2011-2013 among those who declared that a cardiologist in a hospital outpatient clinic decided about the treatment, from 17.5% to 34.0% ( < 0.01) among those treated by a primary care physician, and from 7.0% to 19.7% ( = 0.06) among patients treated in private cardiology practices. The corresponding proportions were 44.6% and 42.4% ( < 0.01), 47.7% and 52.8% ( = 0.53), 44.2% and 42.2% ( = 0.75) for high blood pressure, and 42.5% and 71.2% ( < 0.001), 51.4% and 79.6% ( < 0.001), 52.4% and 72.4% ( < 0.01) for LDL cholesterol level not at recommended goal. The proportion of patients prescribed cardioprotective medications increased in every analyzed group.

CONCLUSIONS

The control of cardiovascular risk in CAD patients has only slightly improved since 1997/98 in all health care settings. The greatest potential for further improvement was found among patients whose post-hospital care is provided by primary care physicians. It is associated with promotion of a no-smoking policy and enhanced prescription of guideline-recommended drugs.

摘要

引言

已确诊冠心病(CAD)的患者发生心血管事件复发的风险很高。本分析的目的是比较初级保健医生和专科医生在实施心血管预防指南方面的时间趋势。

材料与方法

波兰南部五家设有心脏病科的医院参与了该研究,这些医院服务于该市及周边地区。连续入选因急性冠状动脉综合征住院或接受心肌血运重建手术的患者,并在住院后6 - 18个月进行访谈。调查分别在1997 - 1998年、1999 - 2000年、2006 - 2007年和2011 - 2013年进行。

结果

在那些宣称由医院门诊心脏病专家决定治疗方案的患者中,吸烟者比例从1997 - 1998年的16.0%增至2011 - 2013年的16.4%;在由初级保健医生治疗的患者中,吸烟者比例从17.5%增至34.0%(P<0.01);在私立心脏病诊所治疗的患者中,吸烟者比例从7.0%增至19.7%(P = 0.06)。高血压患者的相应比例分别为44.6%和42.4%(P<0.01)、47.7%和52.8%(P = 0.53)、44.2%和42.2%(P = 0.75);低密度脂蛋白胆固醇水平未达推荐目标的患者比例分别为42.5%和71.2%(P<0.001)、51.4%和79.6%(P<0.001)、52.4%和72.4%(P<0.01)。在每个分析组中,开具心脏保护药物的患者比例均有所增加。

结论

自1997/98年以来,在所有医疗环境中,CAD患者心血管风险的控制仅略有改善。在由初级保健医生提供出院后护理的患者中,发现了最大的进一步改善潜力。这与推广无烟政策和增加指南推荐药物的处方有关。

相似文献

1
Practice setting and secondary prevention of coronary artery disease.冠心病的实践环境与二级预防
Arch Med Sci. 2018 Aug;14(5):979-987. doi: 10.5114/aoms.2017.65236. Epub 2017 Jan 19.
2
Secondary prevention of coronary artery disease in contemporary clinical practice.当代临床实践中冠状动脉疾病的二级预防
Cardiol J. 2015;22(2):219-26. doi: 10.5603/CJ.a2014.0066. Epub 2014 Oct 9.
3
Changes in secondary prevention of coronary artery disease in the post-discharge period over the decade 1997-2007. Results of the Cracovian Program for Secondary Prevention of Ischaemic Heart Disease and Polish parts of the EUROASPIRE II and III surveys.1997 年至 2007 年出院后期间冠心病二级预防的变化。克拉科夫缺血性心脏病二级预防计划和 EUROASPIRE II 和 III 调查的波兰部分的结果。
Kardiol Pol. 2009 Dec;67(12):1353-9.
4
Secondary prevention in patients after hospitalisation due to coronary artery disease: what has changed since 2006?冠心病住院患者的二级预防:自2006年以来有哪些变化?
Kardiol Pol. 2014;72(4):355-62. doi: 10.5603/KP.a2013.0350. Epub 2014 Jan 10.
5
Secondary prevention of coronary artery disease in Poland. Results from the POLASPIRE survey.波兰的冠心病二级预防。来自 POLASPIRE 调查的结果。
Cardiol J. 2020;27(5):533-540. doi: 10.5603/CJ.a2020.0072. Epub 2020 May 21.
6
Temporal changes in the secondary prevention of coronary artery disease in patients following myocardial revascularization.心肌血运重建术后患者冠状动脉疾病二级预防的时间变化。
Postepy Kardiol Interwencyjnej. 2020 Dec;16(4):422-428. doi: 10.5114/aic.2020.101767. Epub 2020 Dec 29.
7
Changes over time in the prevention of recurrent coronary artery disease in everyday practice.在日常实践中预防复发性冠状动脉疾病的时间变化。
Pol Arch Intern Med. 2021 Aug 30;131(7-8):673-678. doi: 10.20452/pamw.16001. Epub 2021 May 18.
8
Age, sex, and secondary prevention of ischaemic heart disease in everyday practice.在日常实践中,年龄、性别与缺血性心脏病的二级预防。
Kardiol Pol. 2013;71(12):1251-9. doi: 10.5603/KP.a2013.0148. Epub 2013 Jun 25.
9
Secondary prevention of coronary artery disease in hospital practice over the decade 1996-2006. Results of the Cracovian Program for Secondary Prevention of Ischaemic Heart Disease and Polish parts of the EUROASPIRE II and EUROASPIRE III surveys.1996-2006 年十年间医院实践中的冠心病二级预防。克拉科夫缺血性心脏病二级预防方案和 EUROASPIRE II 及 EUROASPIRE III 调查波兰部分的结果。
Kardiol Pol. 2009 Aug;67(8A):970-7.
10
Factors related to the effectiveness of hypercholesterolemia treatment following hospitalization for coronary artery disease.冠心病住院后高胆固醇血症治疗效果的相关因素。
Pol Arch Med Wewn. 2016 Jun 23;126(6):388-94. doi: 10.20452/pamw.3447.

引用本文的文献

1
Cardiovascular Diseases Among Indian Older Adults: A Comprehensive Review.印度老年人中的心血管疾病:综合综述
Cardiovasc Ther. 2024 Jun 25;2024:6894693. doi: 10.1155/2024/6894693. eCollection 2024.
2
Updates in the Management of Coronary Artery Disease: A Review Article.冠状动脉疾病管理的最新进展:一篇综述文章。
Cureus. 2023 Dec 16;15(12):e50644. doi: 10.7759/cureus.50644. eCollection 2023 Dec.
3
Smoke-free hospitals in Poland - a cross-sectional survey.波兰的无烟医院——一项横断面调查。
Arch Med Sci. 2020 Jun 11;19(6):1795-1801. doi: 10.5114/aoms.2020.96289. eCollection 2023.
4
Treatment goal attainment for secondary prevention in coronary patients with or without diabetes mellitus - Polish multicenter study POLASPIRE.伴有或不伴有糖尿病的冠心病患者二级预防的治疗目标达成情况——波兰多中心研究POLASPIRE
Arch Med Sci. 2020 Jan 23;19(2):305-312. doi: 10.5114/aoms.2020.92558. eCollection 2023.
5
Twelve-month clinical results from the new cobalt-chromium sirolimus-eluting dedicated bifurcation stent BiOSS LIM C Registry.新型钴铬西罗莫司洗脱专用分叉支架BiOSS LIM C注册研究的12个月临床结果。
Arch Med Sci. 2020 Feb 10;19(2):324-330. doi: 10.5114/aoms.2020.92974. eCollection 2023.
6
Nurses' perspectives on the barriers to and facilitators of the implementation of secondary prevention for people with coronary heart disease: a qualitative descriptive study.护士对实施冠心病二级预防障碍和促进因素的看法:定性描述性研究。
BMJ Open. 2022 Sep 26;12(9):e063029. doi: 10.1136/bmjopen-2022-063029.
7
Perioperative Fluoroquinolone Treatment Deteriorates Prognosis Following Coronary Artery Bypass Grafting.围手术期氟喹诺酮类药物治疗会使冠状动脉旁路移植术后的预后恶化。
J Cardiovasc Dev Dis. 2022 May 28;9(6):173. doi: 10.3390/jcdd9060173.
8
Comparison of low-density lipoprotein cholesterol level calculated using the modified Martin/Hopkins estimation or the Friedewald formula with direct homogeneous assay measured low-density lipoprotein cholesterol.使用改良的Martin/Hopkins估算方法或Friedewald公式计算的低密度脂蛋白胆固醇水平与直接匀相测定法测得的低密度脂蛋白胆固醇水平的比较。
Arch Med Sci. 2020 Aug 3;18(3):577-586. doi: 10.5114/aoms.2020.97847. eCollection 2022.
9
Design and rationale of a nationwide screening analysis from the LIPIDOGRAM2015 and LIPIDOGEN2015 studies.来自LIPIDOGRAM2015和LIPIDOGEN2015研究的全国性筛查分析的设计与原理
Arch Med Sci. 2020 Jun 4;18(3):604-616. doi: 10.5114/aoms.2020.96052. eCollection 2022.
10
Utilization of Risk Scores for Coronary Heart Disease Diagnosis in Rural China.中国农村地区冠心病诊断风险评分的应用
Int J Gen Med. 2022 Mar 5;15:2541-2548. doi: 10.2147/IJGM.S355573. eCollection 2022.

本文引用的文献

1
Sleep changes following statin therapy: a systematic review and meta-analysis of randomized placebo-controlled polysomnographic trials.他汀类药物治疗后的睡眠变化:一项对随机安慰剂对照多导睡眠图试验的系统评价和荟萃分析。
Arch Med Sci. 2015 Oct 12;11(5):915-26. doi: 10.5114/aoms.2015.54841.
2
New model of secondary cardiovascular prevention for patients after acute coronary syndromes in Poland with regard to Norwegian experiences.
Kardiol Pol. 2016;74(2):101-3. doi: 10.5603/KP.a2015.0176. Epub 2015 Sep 14.
3
Primary care organisational interventions for secondary prevention of ischaemic heart disease: a systematic review and meta-analysis.缺血性心脏病二级预防的基层医疗组织干预措施:系统评价与荟萃分析
Br J Gen Pract. 2015 Jul;65(636):e460-8. doi: 10.3399/bjgp15X685681.
4
The assessment of coronary heart disease risk factors correlated with demographic and social data in post-coronary intervention patients in Polish population.波兰人群中冠状动脉介入治疗后患者冠心病危险因素与人口统计学和社会数据的相关性评估。
Cardiol J. 2015;22(3):276-84. doi: 10.5603/CJ.a2015.0021.
5
Trends in pharmacological therapy of patients referred for coronary artery bypass grafting between 2004 and 2008: a single-centre study.
Kardiol Pol. 2015;73(12):1317-26. doi: 10.5603/KP.a2015.0094. Epub 2015 May 19.
6
Lipid-lowering therapy in older persons.老年人的降脂治疗。
Arch Med Sci. 2015 Mar 16;11(1):43-56. doi: 10.5114/aoms.2015.48148. Epub 2015 Jan 8.
7
Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel.他汀不耐受 - 统一定义的尝试。国际脂质专家组的立场文件。
Arch Med Sci. 2015 Mar 16;11(1):1-23. doi: 10.5114/aoms.2015.49807. Epub 2015 Mar 14.
8
EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries.欧洲动脉粥样硬化调查项目IV:欧洲心脏病学会对来自24个欧洲国家的冠心病患者的生活方式、危险因素及治疗管理情况的调查。
Eur J Prev Cardiol. 2016 Apr;23(6):636-48. doi: 10.1177/2047487315569401. Epub 2015 Feb 16.
9
Secondary prevention of coronary artery disease in contemporary clinical practice.当代临床实践中冠状动脉疾病的二级预防
Cardiol J. 2015;22(2):219-26. doi: 10.5603/CJ.a2014.0066. Epub 2014 Oct 9.
10
Is the physician's behavior in dyslipidemia diagnosis in accordance with guidelines? Cross-sectional ESCARVAL study.医生在血脂异常诊断中的行为是否符合指南?横断面ESCARVAL研究。
PLoS One. 2014 Mar 13;9(3):e91567. doi: 10.1371/journal.pone.0091567. eCollection 2014.